David Schmahl, CEO
Foundation for the Accreditation of Cellular Therapy (FACT)
United States
On behalf of FACT’s Board of Directors, volunteer leaders, and headquarters’ staff, I’m privileged to share with you highlights of our efforts and outcomes of the past year. The information is a celebration of the value FACT brings to the quality, safety, and access of cellular therapies to patients who need them.
This is also a celebration of the commitment and expertise of FACT’s “army of volunteers” behind our peer-based and consensus-driven efforts. These activities and outcomes reflect the dedication, expertise, and hard work of hundreds of peers who volunteer to advance FACT’s mission. I hope our volunteers take earned pride in their volunteer contributions to FACT. We sincerely appreciate and thank our volunteers.
Equally important to FACT’s daily operational work is the planning and delivery of offerings to assure eligible patients are experiencing quality and safety as cellular therapies expand and evolve. In 2025, FACT re-committed itself to being part of the many solutions needed to bring CAR T therapies closer to where ALL patients live and work. FACT supports the CAR T Vision (see www.cartvision.com) and published critically important “fit for purpose” IEC-in-Community Standards in November.
The information that follows is organized by main areas of FACT’s work and associated service lines, reflecting both the dedication of our Headquarters staff as well as all FACT volunteers – the life-blood of our organization. “FACT Forward” is a phrase we’re using more and more, and you are an essential part of it.
Respectfully and gratefully,
David
#RegionalandPartnerUpdates